ACR Preview: Safe Pregnancies, Heart Health, and Diagnosis by AI

Slideshow

The American College of Rheumatology is holding its annual meeting this week. In this slideshow, we highlight some of the stories we'll be covering from safe pregnancies to hydroxychloroquine safety.

Related Videos
Experts discuss fibromyalgia.
Expert on fibromyalgia.
Expert on fibromyalgia.
Expert on fibromyalgia.
Experts on fibromyalgia.
Expert on fibromyalgia.
Related Content

Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes

September 20th 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

August 31st 2023

Biden Administration, CMS Reveal First 10 Drugs Set for Price Negotiation

August 29th 2023

Relatable Rheumatology: Exploring Chronic Pain in Rheumatic Disease

June 23rd 2023

ACR Introduces Guidelines for Treatment, Management of ILD in Patients with Rheumatic Disease

August 22nd 2023

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023

Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes

September 20th 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

August 31st 2023

Biden Administration, CMS Reveal First 10 Drugs Set for Price Negotiation

August 29th 2023

Relatable Rheumatology: Exploring Chronic Pain in Rheumatic Disease

June 23rd 2023

ACR Introduces Guidelines for Treatment, Management of ILD in Patients with Rheumatic Disease

August 22nd 2023

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023

Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes

September 20th 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

August 31st 2023

Biden Administration, CMS Reveal First 10 Drugs Set for Price Negotiation

August 29th 2023

Relatable Rheumatology: Exploring Chronic Pain in Rheumatic Disease

June 23rd 2023

ACR Introduces Guidelines for Treatment, Management of ILD in Patients with Rheumatic Disease

August 22nd 2023

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023
© 2023 MJH Life Sciences

All rights reserved.